Biodistribution of intravenously injected [14C] doxorubicin and [14C] daunorubicin in mice: Concise communication

Research output: Contribution to journalArticle

Abstract

[14C] doxorubicin (adriamycin) and [14C] daunorubicin (daunomycin) are cardiotoxic antibodies used in cancer therapy. These drugs were examined as possible agents for the measurement of regional myocardial blood flow. The antibiotics were injected intravenously into mice, which were then killed after various intervals. At a chemical dosage of 0.5 mg per kilogram, the content of the heart never exceeded 0.60% of the administered dose for doxorubicin and 0.55% for daunorubicin. The cardiotoxic effect of these drugs, therefore, is probably related to a specific sensitivity of the heart, rather than to an avid uptake of the drugs by the cardiac muscle. Further studies seem warranted, using a lower chemical dosage and higher specific activity.

Original languageEnglish (US)
Pages (from-to)84-86
Number of pages3
JournalJournal of Nuclear Medicine
Volume19
Issue number1
StatePublished - 1978

Fingerprint

Daunorubicin
Doxorubicin
Communication
Pharmaceutical Preparations
Regional Blood Flow
Myocardium
Anti-Bacterial Agents
Antibodies
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

@article{9ccfb1f6d25b4f5c92597b180efe9408,
title = "Biodistribution of intravenously injected [14C] doxorubicin and [14C] daunorubicin in mice: Concise communication",
abstract = "[14C] doxorubicin (adriamycin) and [14C] daunorubicin (daunomycin) are cardiotoxic antibodies used in cancer therapy. These drugs were examined as possible agents for the measurement of regional myocardial blood flow. The antibiotics were injected intravenously into mice, which were then killed after various intervals. At a chemical dosage of 0.5 mg per kilogram, the content of the heart never exceeded 0.60{\%} of the administered dose for doxorubicin and 0.55{\%} for daunorubicin. The cardiotoxic effect of these drugs, therefore, is probably related to a specific sensitivity of the heart, rather than to an avid uptake of the drugs by the cardiac muscle. Further studies seem warranted, using a lower chemical dosage and higher specific activity.",
author = "Harrison, {Katharine Santos} and Wagner, {H. N.}",
year = "1978",
language = "English (US)",
volume = "19",
pages = "84--86",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "1",

}

TY - JOUR

T1 - Biodistribution of intravenously injected [14C] doxorubicin and [14C] daunorubicin in mice

T2 - Concise communication

AU - Harrison, Katharine Santos

AU - Wagner, H. N.

PY - 1978

Y1 - 1978

N2 - [14C] doxorubicin (adriamycin) and [14C] daunorubicin (daunomycin) are cardiotoxic antibodies used in cancer therapy. These drugs were examined as possible agents for the measurement of regional myocardial blood flow. The antibiotics were injected intravenously into mice, which were then killed after various intervals. At a chemical dosage of 0.5 mg per kilogram, the content of the heart never exceeded 0.60% of the administered dose for doxorubicin and 0.55% for daunorubicin. The cardiotoxic effect of these drugs, therefore, is probably related to a specific sensitivity of the heart, rather than to an avid uptake of the drugs by the cardiac muscle. Further studies seem warranted, using a lower chemical dosage and higher specific activity.

AB - [14C] doxorubicin (adriamycin) and [14C] daunorubicin (daunomycin) are cardiotoxic antibodies used in cancer therapy. These drugs were examined as possible agents for the measurement of regional myocardial blood flow. The antibiotics were injected intravenously into mice, which were then killed after various intervals. At a chemical dosage of 0.5 mg per kilogram, the content of the heart never exceeded 0.60% of the administered dose for doxorubicin and 0.55% for daunorubicin. The cardiotoxic effect of these drugs, therefore, is probably related to a specific sensitivity of the heart, rather than to an avid uptake of the drugs by the cardiac muscle. Further studies seem warranted, using a lower chemical dosage and higher specific activity.

UR - http://www.scopus.com/inward/record.url?scp=0017840523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017840523&partnerID=8YFLogxK

M3 - Article

C2 - 621570

AN - SCOPUS:0017840523

VL - 19

SP - 84

EP - 86

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 1

ER -